Bone-marrow-derived multipotent progenitor stromal cells — or mesenchymal stem cells (MSCs ... components of the haematopoietic stem cell (HSC) niche that support HSC homeostasis and ...

The license agreement grants PranaX access to a core patent portfolio covering exosome manufacturing ... first FDA approved trial to test mesenchymal stem cell derived exosomes in cancer patients.

The licensed technology was part of the first FDA approved trial to test mesenchymal stem cell ... is a physician-directed, GMP stem cell exosome supplement for application in health and wellness.

While the trial focuses on stem cell transplantation, it hints at broader mechanisms—like exosome release—that could transform Parkinson's care by repairing brain damage and enhancing dopamine ...

The licensed technology was part of the first FDA approved trial to test mesenchymal stem cell derived exosomes in cancer patients. The company's first commercial product, ExoWELL™, is a ...

We were the first lupus organization in the U.S. to support stromal cell research. In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over ...

“Mesenchymal stem cells ... They play a key role in cell-to-cell communication, helping to transfer growth factors and ...

RoosterBio team members at a TEDCO event. (Courtesy TEDCO) RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and exosome/extracellular vesicle (EV) product and process development to ...